Table II.
Univariate Prevalence Risk Ratios | 95%CIb | p | Multivariate Prevalence Risk Ratiosc | 95% CI | p | |
---|---|---|---|---|---|---|
Age groupd | ||||||
<20 | 1.0 (ref) | - | ||||
20–29 | 2.94 | 1.09–7.93 | 0.033 | 2.63 | 0.98–7.12 | 0.056 |
30–49 | 3.95 | 1.54–10.10 | 0.004 | 3.37 | 1.31–8.66 | 0.012 |
≥50 | 5.05 | 1.97–13.0 | 0.001 | 4.37 | 1.70–11.2 | 0.002 |
Male gender | 1.06 | 0.84–1.32 | 0.636 | 1.07 | 0.85–1.35 | 0.566 |
3+ Lifetime sex partners | 1.51 | 1.15–1.99 | 0.003 | 1.27 | 0.95–1.69 | 0.101 |
Regularly use condoms | 1.11 | 0.76–1.63 | 0.569 | |||
Prior blood transfusions | 1.39 | 0.75–2.67 | 0.320 | |||
Recent medical injections | 1.01 | 0.80–1.26 | 0.941 | |||
HIV-1 infected | 1.31 | 1.00–1.73 | 0.048 | 1.31 | 1.00–1.71 | 0.046 |
Syphilis seroreactivee | 1.49 | 1.12–2.01 | 0.007 | 1.35 | 1.01–1.79 | 0.039 |
HBV infection defined as expression of anti-HBc and/or HBsAg
CI, confidence intervals
All variables with p<0.1 in univariate analysis were included in the multivariate model
Age in years
Reactive on nontreponemal screening test, including RPR (reactive plasma reagin) or TRUST (toludine red unheated serum test)